• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:袁腾腾,常红,唐亚楠,吕淑婕,方亮,王雷,陈卫东,张彩云.芍药苷及芍药苷磷脂复合物胶束在体肠吸收对比分析[J].药学研究,2023,42(8):562-566,573[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2421次   下载 2354次 本文二维码信息
码上扫一扫!
芍药苷及芍药苷磷脂复合物胶束在体肠吸收对比分析
袁腾腾1,2,3,4,常红1,2,3,4,唐亚楠1,2,3,4,吕淑婕1,2,3,4,方亮1,2,3,4,王雷1,2,3,4,陈卫东1,2,3,4,张彩云1,2,3,4
字体:加大+|默认|缩小-
(1.安徽中医药大学药学院,药物制剂技术与应用安徽省重点实验室,安徽 合肥 230012;2.安徽省教育厅现代药物制剂工程技术研究中心,安徽 合肥 230012;3.中药复方安徽省重点实验室,安徽 合肥 230012;4.安徽省道地中药材品质提升创新协同中心,安徽 合肥 230012)
摘要:
目的比较芍药苷(PF)和芍药苷磷脂复合物(PF-PLC)胶束的肠吸收特点,探讨磷脂复合物胶束提高PF生物利用度的作用机制。方法采用大鼠在体单向肠灌流模型,以吸收速率常数(Ka)和有效渗透系数(Peff)为指标,通过超高相液相色谱(UPLC)测定不同浓度PF原料药和PF-PLC胶束在十二指肠中的肠吸收情况。同时,在灌流液中添加维拉帕米,考察P-糖蛋白(P-gp)抑制剂对PF原料药和PF-PLC胶束肠吸收的影响。结果PF-PLC胶束浓度的提高可显著增加PF的肠道吸收(P<0.001,P<0.05)。在灌流液中加入维拉帕米后发现,与单纯PF组比较,PF+维拉帕米组的Ka和Peff值虽有增加的趋势,但无明显统计学差异;与PF-PLC胶束组比较,PF-PLC胶束+维拉帕米组差异也无统计学意义。结论大鼠在体单向肠灌流实验结果显示PF-PLC胶束的吸收主要是被动转运途径,且磷脂复合物胶束的形成显著改善了PF在十二指肠的吸收。维拉帕米的加入对PF-PLC胶束的吸收无显著影响,即PF-PLC胶束的吸收不受外排转运体的影响,这可能是生物利用度提高的原因之一。
关键词:  芍药苷  磷脂复合物  胶束  肠吸收  P-糖蛋白  在体单向肠灌流
DOI:10.13506/j.cnki.jpr.2023.08.005
基金项目:国家自然科学基金项目(No.51303006);安徽省教育厅基金项目(No.KJ2021ZD0065);安徽省重大专项(No.202203a07020031);省级大学生创新创业项目(No.S202110369017)
出版日期:2023-08-25
Comparative study of paeoniflorin and paeoniflorin phospholipid complex micelles in intestinal absorption
YUAN Tengteng1,2,3,4,CHANG Hong1,2,3,4,TANG Yanan1,2,3,4,LYU Shujie1,2,3,4,FANG Liang1,2,3,4,WANG Lei1,2,3,4,CHEN Weidong1,2,3,4,ZHANG Caiyun1,2,3,4
(1. School of Pharmacy, Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Anhui University of Traditional Chinese Medicine, Hefei 230012,China; 2. Engineering Technology Research Center of Modernized Pharmaceutics, Hefei 23001,China 2; 3. Anhui Key Laboratory of Compound Chinese Materia Medica, Hefei 230012, China; 4. Anhui Genuine Chinese Medicinal Materials Quality Improvement Innovation Collaborative Center, Hefei 230012,China)
Abstract:
Objective To compare the intestinal absorption characteristics of paeoniflorin (PF) and paeoniflorin phospholipid complex (PF-PLC) micelles, and to explore the mechanism of enhancing bioavailability of PF with nano- micelles.Methods The intestinal absorption characteristics of PF and PF-PLC micelles in duodenum at different concentrations were determined by ultra-high phase liquid chromatography (UPLC) with the absorption rate constant (Ka) and effective permeability coefficient (Peff) as indexes. Meanwhile, verapamil was added into the perfusion solution to investigate the effect of P-glycoprotein (P-gp) inhibitor on intestinal absorption of PF and PF-PLC micelles.Results The increase of PF-PLC micelles concentration significantly increased intestinal absorption of PF (P<0.001, P<0.05). After adding verapamil into the irrigation fluid, Ka and Peff values of PF+verapamil group showed an increasing trend, but no significant difference compared with PF group. Compared with the PF-PLC micelles group, there was no significant difference in PF-PLC micelles+verapamil group. Conclusion In vivo unidirectional intestinal perfusion experiment in rats showed that the absorption of PF-PLC micelles mainly existed passive transport pathway and the formation of phospholipid complex micelles significantly improved the absorption of PF in duodenum. The addition of verapamil had no significant effect on the absorption of PF-PLC micelles, that is, the absorption of PF-PLC micelles was not affected by efflux transporters, which may be one of the reasons for the improvement of bioavailability.
Key words:  Paeoniflorin  Phospholipid complex  Micelles  Intestinal absorption  P-glycoprotein  Unidirectional intestinal perfusion in vivo
今日访问量:2427    总访问量:55338838
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司